News
FRANKLIN, WI, March 6, 2025 – Tiger Aesthetics Medical, LLC is pleased to announce a $50 million investment into its manufacturing operations with the construction of a state-of-the-art new facility in Wisconsin to support the long-term growth and profitability of its Breast Augmentation and Reconstruction business.
Read MoreFRANKLIN, WI, November 8, 2024 – Tiger Aesthetics Medical, LLC, a division of Tiger BioSciences, is pleased to announce the acquisition of Revelle Aesthetics, Inc, makers of the groundbreaking Avéli® cellulite reduction device which is FDA cleared as a one-time treatment with long-term results. This acquisition broadens the commercial impact of the Tiger Aesthetics portfolio into the fast-growing field of regenerative body aesthetics.
Read MoreFRANKLIN, WI, October 17, 2024 – Tiger Aesthetics Medical, LLC, a division of Tiger BioSciences, is pleased to announce the acquisition of select assets from Suneva Medical, Inc., an innovative medical technology company pioneering regenerative aesthetics. This strategic acquisition is set to further strengthen Tiger Aesthetics’ market presence in regenerative aesthetics and complements the company’s upcoming adipose cell and tissue products, alloClae™ and dermaClae™.
Read MoreFRANKLIN, WI, April 24, 2024 — Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated with the Sientra Inc. breast implant business. This strategic acquisition will complement Tiger Aesthetics’ upcoming adipose cell and tissue product launches designed to provide new treatment options for plastic surgeons and patients. Moving forward, Sientra will become a division of Tiger Aesthetics Medical LLC.
Read More
